FDA approves first generics of Lyrica
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Bearish Options Positioning in Teva Pharma (TEVA) Targets Downside in Shares Through January -Susquehanna
July 22, 2019 1:48 PM EDTSusquehanna options strategist Alison Edwards notes bearish options positioning in Teva Pharma (NYSE: TEVA), as investors bought 22k Jan 9 Puts for $2.10. The investors buy volatility, suggesting the shares have an increased probability to trade below their breakeven of ~$6.90 (-10%).
... More



